Avrobio Plots Comeback With Early Data From Gaucher’s Gene Therapy
Sees Bluebird Success As Creating Pathway
Early data in Gaucher disease suggest Avrobio’s hematopoietic stem cell gene therapy could help patients who do not response to enzyme replacement therapy.
